DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01055847 (ClinicalTrials.gov)	June 2003	23/1/2010	Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection	A Blinded, Multicenter, Randomized, Placebo-Controlled Trial With Aztreonam for Inhalation (AI) in Cystic Fibrosis Patient With Lung Disease Due to P. Aeruginosa Infection	Cystic Fibrosis;CF;Lung Infection;Pseudomonas Aeruginosa	Drug: Aztreonam for Inhalation (AI);Drug: Placebo	Gilead Sciences	Conducted under Salus Pharma, Inc.	Completed	13 Years	N/A	Both	105	Phase 2	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT01055847
(ClinicalTrials.gov)

June 2003

23/1/2010

Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection

A Blinded, Multicenter, Randomized, Placebo-Controlled Trial With Aztreonam for Inhalation (AI) in Cystic Fibrosis Patient With Lung Disease Due to P. Aeruginosa Infection

Cystic Fibrosis;CF;Lung Infection;Pseudomonas Aeruginosa

Drug: Aztreonam for Inhalation (AI);Drug: Placebo

Gilead Sciences

Conducted under Salus Pharma, Inc.

Completed

13 Years

N/A

Both

105

Phase 2

United States